Role of IL-5R Signaling in Non-eosinophil Upper Airway Cells in CRSwNP
NCT05672030 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2025-11-24
Summary
The overarching hypothesis of this proposal is that IL-5 acts on multiple sinus tissue cell types, including plasma cells and epithelial cells, to promote immune dysregulation, and that inhibition of IL-5 affects several relevant effector pathways that lead to clinical benefit.
Conditions
- Nasal Polyps
- Aspirin-exacerbated Respiratory Disease
Interventions
- OTHER
-
Non-Interventional
No intervention.
Sponsors & Collaborators
-
Brigham and Women's Hospital
lead OTHER
Principal Investigators
-
Tanya Laidlaw · Brigham and Women's Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-10-01
- Primary Completion
- 2023-12-01
- Completion
- 2023-12-01
Countries
- United States
Study Locations
More Related Trials
-
Comparison of Immune Profiles in Chronic Rhinosinusitis Patients After Mepolizumab Treatment
NCT05642806 ·Status: RECRUITING ·Phase: PHASE4
-
Qualitative Analysis of Subject Experience of Nasal Polyps
NCT03221192 ·Status: COMPLETED
-
Study of Chronic Rhinosinusitis Symptoms in Asthma Patients Undergoing Treatment With Reslizumab
NCT03369574 ·Status: WITHDRAWN
-
Predictive Factors in Chronic Rhinosinusitis With Nasal Polyps
NCT06459622 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
th2 Modulation CRSwNP
NCT06107101 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Endotypic Stability in CRS
NCT06272123 ·Status: RECRUITING
-
Role of Epithelial Barrier Integrity in Biologic Treatment Response of Severe Asthmatics With/Out Chronic Rhinosinusitis With Nasal Polyps (CRSwNP).
NCT05365841 ·Status: RECRUITING
-
A Study of GR1802 in Participants With Chronic Sinusitis With Nasal Polyps
NCT06516302 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Identifying Predictors Of Response To Mepolizumab In CRSwNP
NCT05902325 ·Status: RECRUITING ·Phase: PHASE4
-
Biologics in Chronic Rhinosinusitis With Nasal Polyposis
NCT06824649 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
BIOlogics in Severe Nasal POlyposis SurvEy
NCT05228041 ·Status: ACTIVE_NOT_RECRUITING
-
A Study in Male and Female Adult Participants With Chronic Rhinosinusitis With Nasal Polyps In the Greater Gulf Region
NCT05649813 ·Status: COMPLETED
-
Correlation Between the Microbiome and Type 2 Inflammatory Diseases of CRSwNP
NCT06231004 ·Status: NOT_YET_RECRUITING
-
Dupilumab in Chinese Adult Participants With CRSwNP
NCT05878093 ·Status: COMPLETED ·Phase: PHASE3
-
Systemic Corticosteroids in the Perioperative Management of Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)
NCT02119273 ·Status: WITHDRAWN ·Phase: PHASE4
-
Dupilumab Treatment Effects in an Ethnically Diverse Population With Chronic Rhinosinusitis With Nasal Polyposis
NCT05246267 ·Status: RECRUITING
-
Establishment of Precise Diagnosis and Treatment System for Refractory Chronic Rhinosinusitis
NCT05390255 ·Status: UNKNOWN ·Phase: PHASE3
-
The Study of GR1802 in Patients with Chronic Rhinosinusitis with Nasal Polyps
NCT05873803 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Biomarkers of Response to Mepolizumab Treatment in Patients With Nasal Polyps With or Without Bronchial Asthma
NCT05708300 ·Status: RECRUITING
-
Blown Nasal Secretion Measurements in Rhinosinusitis: Repeatability and Validity Compared to Nasal Lavage
NCT00292851 ·Status: COMPLETED
-
Subcutaneous Omalizumab for Treatment of Chronic Rhinosinusitis With Nasal Polyposis
NCT01066104 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Mepolizumab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)/ Eosinophilic Chronic Rhinosinusitis (ECRS)
NCT04607005 ·Status: COMPLETED ·Phase: PHASE3
-
Mepolizumab in the Treatment of Patients With Severe Uncontrolled CRSwNP: a Multicentric Real Life Observational Study
NCT06258772 ·Status: NOT_YET_RECRUITING
-
A Cohort Study on Biomarkers to Predict the Efficacy of Biologics for Chronic Rhinosinusitis with Nasal Polyps
NCT06801353 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
GB001 in Adult Participants With Chronic Rhinosinusitis
NCT03956862 ·Status: COMPLETED ·Phase: PHASE2